-
Dreamworks Animation SKG (DWA) Climbs After Upgrade To Overweight
Wednesday, February 17, 2010 - 8:51pm | 75Read More...Shares of Dreamworks Animation SKG, Inc. (Nasdaq: DWA) closed nearly 3% higher than the prior trading days' close. Th stock price received a boost when the stock was upgraded by Thomas Weisel Partners analyst Benjamin Mogil from Market Weight to Overweight. Mogil also increased his price target...
-
BPZ Resources, Inc. (BPZ) Offers A Compelling Valuation
Friday, February 5, 2010 - 5:16pm | 159Read More...Analysts at Thomas Weisel Partners Group, Inc. (NASDAQ: TWPG) have released an update on BPZ Resources, Inc. (NYSE: BPZ). The company has announced a $140 million offering of 6.5% convertible notes due 2015. The notes will be convertible, subject to certain conditions, into common shares at $6.74...
-
FCS Upgraded, TP Raised
Wednesday, January 20, 2010 - 4:05pm | 116Read More...Analysts at Thomas Weisel Partners upgrade Fairchild Semiconductor International Inc (NYSE: FCS) from “underweight” to “market weight.” The target price for FCS has been raised from $8 to $9. Fairchild Semiconductor International is poised for “optimum capacity utilization over the next few...
-
IBM - Large Software Deals Slip Into 1Q10
Wednesday, January 20, 2010 - 4:01pm | 207Read More...Analysts at Thomas Weisel Partners reiterate their “overweight” rating on International Business Machines Corporation (NYSE: IBM). The target price for IBM is set to $150. IBM has announced 4Q09 software revenues at $6.58 billion, missing the estimate on account of some large deals slipping into 1Q...
-
Fairchild Semiconductor International, Inc. (FCS) Upgraded To Market Weight
Wednesday, January 20, 2010 - 2:11pm | 121Read More...Analysts from Thomas Weisel Partners have upgraded Fairchild Semiconductor International, Inc. (NYSE: FCS) to market weight on improved 2010 prospects. With the recovery having played out more rapidly than anticipated, analysts believe Fairchild is positioned for optimum capacity utilization over...
-
DOX To Benefit From Opportunities At AT&T
Tuesday, January 19, 2010 - 3:33pm | 148Read More...Analysts at Thomas Weisel Partners reiterate their “overweight” rating on Amdocs Limited (NYSE: DOX). The target price for DOX has been raised from $32 to $35. Amdocs is likely to report its 1Q10 revenues and EPS at $710 million and $0.52, respectively, marginally short of the consensus...
-
Upside To GOOG EPS
Tuesday, January 19, 2010 - 3:31pm | 143Read More...Analysts at Thomas Weisel Partners reiterate their “overweight” rating on Google (NASDAQ: GOOG), while raising their estimates for the company. The target price for GOOG is set to $675. Google is scheduled to announce its 4Q earnings results on January 21. The analysts expect the company to beat...
-
NTRI Suffers Lackluster Uptake Of Cards
Tuesday, January 19, 2010 - 2:18pm | 97Read More...Analysts at Thomas Weisel Partners reiterate their “market weight” rating on NutriSystem Inc (NASDAQ: NTRI), while reducing their estimates for the company. The target price for NTRI is set to $24. NutriSystem’s recent retail initiatives have been impressive. However, channel checks indicate...
-
Broadband Stimulus Delays To Impact ADTN Growth
Tuesday, January 19, 2010 - 11:10am | 109Read More...Analysts at Thomas Weisel Partners reiterate their “overweight” rating on Adtran Inc (NASDAQ: ADTN), while reducing their estimates for the company. The target price for ADTN has been reduced from $32 to $28. Adtran is likely to report its FY4Q09 results inline with the consensus expectations. The...
-
ISIS Rides On Cardio (ISIS)
Tuesday, January 12, 2010 - 10:32am | 101Read More...Analysts at Thomas Weisel Partners have reiterated a Buy rating for ISIS Pharmaceuticals Inc. (NASDAQ: ISIS) with a price target of $21 per share. ISIS currently trades at just over 2x cash, thus providing attractive upside potential. ISIS recently announced the addition of therapeutic drug...
-
Luminex Beats Street Expectations (LMNX)
Tuesday, January 12, 2010 - 9:01am | 107Read More...Luminex Corporation (NASDAQ: LMNX) released a 8-K filing in which the company tightened and lowered its 2009 full year guidance from $118mn-$126mn to $119mn-$121mn. This implies a 4Q revenue guidance of $ 36.5mn to $38.5mn above consensus estimates of $34.7 million. Analysts at Thomas Weisel...
-
NKE Has Significant Growth Opportunities, Operational Excellence
Monday, January 11, 2010 - 11:22am | 110Read More...Analysts at Thomas Weisel Partners maintain their "overweight" rating on NIKE Inc (NYSE: NKE). The target price for NKE is set to $70. According to Thomas Weisel Partners, NIKE is expected to achieve the above-consensus estimates for 2010. In a recent meeting, NKE showcased innovation and product...
-
Fundamentals Intact At Genomic Health Inc. (GHDX)
Friday, January 8, 2010 - 12:44pm | 79Read More...Analysts at Thomas Weisel Partners have reiterated Overweight rating for Genomic Health Inc (NASDAQ: GHDX). Genomic’s 4Q09 revenue was below consensus but this is expected to be a short term blip as there were delay in cash payments from a major client. A price target of $23.00 has been assigned...
-
Keithley Instruments Set To Climb Up (KEI)
Friday, January 8, 2010 - 12:20pm | 80Read More...Analysts at Thomas Weisel Partners have reiterated an Overweight rating for Keithley Instruments Inc. (NYSE: KEI) and revised their price targets upwards from $6.00 to $7.00. Keithley is expected to post revenues of $27-$28 million for F1Q against previous guidance of $23-$27 million. The company...
-
New Product Launches May Not Take The Pressure Off Dell (DELL, T)
Friday, January 8, 2010 - 11:37am | 95Read More...Analysts at Thomas Weisel Partners have reiterated Marketweight rating for Dell (NASDAQ: DELL) with a price target of $16. Dell is set to launch a smart-phone termed Mini 3 which would sell exclusively through AT&T (NYSE: T) networks. Dell is also set to introduce new product launches in the...

